NO20043209L - Fremstilling av A9 tetrahydrocannabinol - Google Patents
Fremstilling av A9 tetrahydrocannabinolInfo
- Publication number
- NO20043209L NO20043209L NO20043209A NO20043209A NO20043209L NO 20043209 L NO20043209 L NO 20043209L NO 20043209 A NO20043209 A NO 20043209A NO 20043209 A NO20043209 A NO 20043209A NO 20043209 L NO20043209 L NO 20043209L
- Authority
- NO
- Norway
- Prior art keywords
- acid
- thc
- converted
- tetrahydrocannabinol
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Electric Double-Layer Capacitors Or The Like (AREA)
- Optical Integrated Circuits (AREA)
- Extraction Or Liquid Replacement (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0202396A GB0202396D0 (en) | 2002-02-01 | 2002-02-01 | Production of delta 9 tetrahydrocannabinol |
GB0214022A GB0214022D0 (en) | 2002-02-01 | 2002-06-18 | Production of delta 9 tetrahydrocannabinol |
PCT/GB2003/000441 WO2003064407A2 (en) | 2002-02-01 | 2003-02-03 | Production of δ9 tetrahydrocannabinol |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20043209L true NO20043209L (no) | 2004-10-28 |
Family
ID=27665366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043209A NO20043209L (no) | 2002-02-01 | 2004-07-28 | Fremstilling av A9 tetrahydrocannabinol |
Country Status (17)
Country | Link |
---|---|
US (3) | US7524881B2 (no) |
EP (2) | EP1474412B1 (no) |
JP (1) | JP2005526715A (no) |
CN (2) | CN100999513A (no) |
AT (1) | ATE396984T1 (no) |
AU (2) | AU2003205844B2 (no) |
BR (1) | BR0307330A (no) |
CA (1) | CA2474951A1 (no) |
DE (2) | DE60321318D1 (no) |
DK (1) | DK1474412T3 (no) |
ES (1) | ES2305437T3 (no) |
NO (1) | NO20043209L (no) |
NZ (2) | NZ552547A (no) |
PT (1) | PT1474412E (no) |
SI (1) | SI1474412T1 (no) |
WO (1) | WO2003064407A2 (no) |
ZA (1) | ZA200405938B (no) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1474412T3 (da) * | 2002-02-01 | 2008-09-01 | Resolution Chemicals Ltd | Fremstilling af delta-9-tetrahydrocannabinol |
PL226646B1 (pl) * | 2002-08-14 | 2017-08-31 | Gw Pharma Ltd | Botaniczna substancja lekowa |
GB2391865B (en) * | 2002-08-14 | 2005-06-01 | Gw Pharma Ltd | Improvements in the extraction of pharmaceutically active components from plant materials |
GB2408978B (en) * | 2002-09-23 | 2006-04-05 | Gw Pharma Ltd | Methods of preparing delta-9 tetrahydrocannabinol from plant material |
GB0222077D0 (en) | 2002-09-23 | 2002-10-30 | Gw Pharma Ltd | Methods of preparing cannabinoids from plant material |
TWI369203B (en) | 2004-11-22 | 2012-08-01 | Euro Celtique Sa | Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol |
AU2005314021B2 (en) * | 2004-12-09 | 2010-02-11 | Insys Therapeutics, Inc. | Room-temperature stable dronabinol formulations |
TWI366460B (en) * | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
EP2578577A1 (en) * | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof |
US20080112895A1 (en) * | 2006-08-04 | 2008-05-15 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
US20080103193A1 (en) * | 2006-10-26 | 2008-05-01 | Trevor Percival Castor | Methods for making compositions and compositions for treating pain and cachexia |
GB0703284D0 (en) | 2007-02-20 | 2007-03-28 | Resolution Chemicals Ltd | Delta 9 - tetrahydrocannabinol processing |
CA2698752A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
US20090042974A1 (en) * | 2007-08-07 | 2009-02-12 | Anson David Parker | Compositions And Methods Relating To Extensible Transgenic Vector Assembler, Pestilence Ridder, Plus Cannabinoid Producer |
GB0807915D0 (en) * | 2008-05-01 | 2008-06-04 | Resolution Chemicals Ltd | Production of delta 9 tetrahydrocannabinol |
US8343553B2 (en) | 2011-04-18 | 2013-01-01 | Hospodor Andrew D | Essential element extractor |
ES2806034T3 (es) * | 2011-09-29 | 2021-02-16 | Thc Pharm Gmbh The Health Concept | Acidos carboxílicos de cannabinoide, sales de ácidos carboxílicos de cannabinoide, su preparación y aplicaciones |
US9358259B2 (en) | 2012-03-20 | 2016-06-07 | Andrew David Hospodor | Recycling cannabinoid extractor |
JP2015515977A (ja) * | 2012-05-03 | 2015-06-04 | エコ・ファーマシューティカルズ・ビー.ブイ.Echo Pharmaceuticals B.V. | Δ9−テトラヒドロカンナビノールを含む大麻草単離物及びこのような単離物を製造するための方法 |
US20130337052A1 (en) * | 2012-06-19 | 2013-12-19 | Patricia Linert | System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication |
US9155767B2 (en) | 2012-10-18 | 2015-10-13 | Andrew D. Hospodor | Essential element management |
WO2014159688A1 (en) * | 2013-03-14 | 2014-10-02 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
US9199960B2 (en) * | 2013-05-02 | 2015-12-01 | Frederick R. Ferri | Method and apparatus for processing herbaceous plant materials including the cannabis plant |
US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
US20170312327A1 (en) * | 2014-11-17 | 2017-11-02 | Connoisseur Holdings, Llc | Extraction devices, systems, and methods |
CA2977421C (en) * | 2015-01-22 | 2022-10-18 | Phytoplant Research S.L. | Methods of purifying cannabinoids, compositions and kits thereof |
US10207198B2 (en) * | 2015-01-22 | 2019-02-19 | Phytoplant Research S.L. | Methods of purifying cannabinoids using liquid:liquid chromatography |
US11034639B2 (en) | 2015-01-22 | 2021-06-15 | Phytoplant Research S.L. | Methods of purifying cannabinoids using liquid:liquid chromatography |
US11040295B2 (en) | 2015-02-06 | 2021-06-22 | Joseph Francis Payack | Method and apparatus for extracting plant oils using ethanol water |
US10059684B2 (en) | 2015-05-07 | 2018-08-28 | Axim Biotechnologies, Inc. | Process to extract and purify Δ9-tetrahydrocannabinol |
US10913071B2 (en) | 2016-03-09 | 2021-02-09 | Pearson Incorporated | Scalper apparatus and processing system |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
WO2018000094A1 (en) | 2016-06-29 | 2018-01-04 | CannScience Innovations Inc. | Decarboxylated cannabis resins, uses thereof and methods of making same |
US10322487B1 (en) | 2016-07-15 | 2019-06-18 | Pearson Incorporated | Roller mill grinding apparatus with regenerative capability |
US9908832B2 (en) * | 2016-07-15 | 2018-03-06 | S.S. Steiner, Inc. | Decarboxylation of cannabidiolic acid in hemp biomass and hemp extract |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
US10702495B2 (en) | 2017-02-20 | 2020-07-07 | Nexien Biopharma, Inc. | Method and compositions for treating dystrophies and myotonia |
US10807098B1 (en) | 2017-07-26 | 2020-10-20 | Pearson Incorporated | Systems and methods for step grinding |
IT201700085508A1 (it) * | 2017-07-26 | 2019-01-26 | Inalco S R L | Metodo per la produzione di cannabinoidi da varietà di canapa industriale |
US10272360B2 (en) | 2017-08-05 | 2019-04-30 | Priya Naturals, Inc. | Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto |
US10406453B2 (en) * | 2017-09-29 | 2019-09-10 | NextLeaf Solutions Ltd. | Cannabinoid extraction process using brine |
US10941102B2 (en) * | 2017-11-29 | 2021-03-09 | Robert Henry Wohleb | Aqueous leaching method to produce microcrystalline powder |
CA3089490A1 (en) * | 2018-01-29 | 2019-08-01 | Phytoplant Research S.L | Methods of purifying cannabinoids using liquid:liquid chromatography |
EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
US11325133B1 (en) | 2018-07-26 | 2022-05-10 | Pearson Incorporated | Systems and methods for monitoring the roll diameter and shock loads in a milling apparatus |
WO2020060959A1 (en) * | 2018-09-17 | 2020-03-26 | Sorbent Technologies, Inc. | Methods for removing contaminants from plant-derived pharmaceuticals |
EP3864000A4 (en) | 2018-10-10 | 2022-08-10 | Treehouse Biosciences, Inc. | CANNABIGEROL SYNTHESIS |
US10751722B1 (en) | 2018-10-24 | 2020-08-25 | Pearson Incorporated | System for processing cannabis crop materials |
CA3127092A1 (en) * | 2019-01-17 | 2020-07-23 | Michaela MULHARE | Solid micellar compositions of cannabinoid acids |
US10785906B2 (en) | 2019-02-19 | 2020-09-29 | Pearson Incorporated | Plant processing system |
KR20220007855A (ko) * | 2019-03-24 | 2022-01-19 | 오메가 라이프 사이언스 리미티드 | 전자 담배 |
WO2020210119A1 (en) | 2019-04-11 | 2020-10-15 | Mantrose-Haeuser Co., Inc. | Cannabis delivery with protective glaze coating |
US11370767B2 (en) | 2019-04-23 | 2022-06-28 | Soma Oil Llc | Cannabis processing systems and methods |
EP3750528A1 (en) | 2019-06-11 | 2020-12-16 | Nexien Biopharma, Inc. | Compositions for treating dystrophies and myotonia |
EP4030941A1 (en) | 2019-09-16 | 2022-07-27 | Vapor Cartridge Technology LLC | Drug delivery system with stackable substrates |
US10757860B1 (en) | 2019-10-31 | 2020-09-01 | Hemp Processing Solutions, LLC | Stripper apparatus crop harvesting system |
US10933424B1 (en) | 2019-12-11 | 2021-03-02 | Pearson Incorporated | Grinding roll improvements |
CN111039760A (zh) * | 2019-12-16 | 2020-04-21 | 福建省中科生物股份有限公司 | 一种制备酚类化合物的方法 |
US11351476B2 (en) * | 2020-01-07 | 2022-06-07 | Agrify Corporation | Method for chemical separation of cannabinoids |
CA3179204A1 (en) * | 2020-06-09 | 2021-12-16 | David A. Fisher | Process for isolation and purification of thca from cannabis |
CA3191486A1 (en) | 2020-09-04 | 2022-03-10 | Giovanni VENTURINI DEL GRECO | Thc-free cannabinoid concentrate, method of obtaining the same and use thereof |
US11242328B1 (en) * | 2021-02-25 | 2022-02-08 | Acid Neutral Alkaline Laboratory | Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans |
US11352337B1 (en) * | 2021-06-02 | 2022-06-07 | Acid Neutral Alkaline Laboratory | Zeolite catalyst and method for preparation of aromatic tricyclic pyrans |
CN115260005B (zh) * | 2022-08-30 | 2024-01-30 | 晨光生物科技集团股份有限公司 | 一种纯化提取大麻二酚的方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342971A (en) * | 1992-12-29 | 1994-08-30 | The Australian National University | Process for the preparation of dibenzo[b,d]pyrans |
EP0824320A4 (en) | 1995-05-05 | 2000-06-07 | Hauser Inc | HIGH PURE CARNOSIC ACID FROM ROSEMARY AND SAGE EXTRACTS BY PH-CONTROLLED FALLING |
GB9726916D0 (en) * | 1997-12-19 | 1998-02-18 | Danbiosyst Uk | Nasal formulation |
US6730519B2 (en) * | 1998-10-26 | 2004-05-04 | The University Of Mississippi | Method of preparing delta-9-tetrahydrocannabinol |
US6365416B1 (en) * | 1998-10-26 | 2002-04-02 | The University Of Mississippi | Method of preparing delta-9-tetrahydrocannabinol |
DK1474412T3 (da) * | 2002-02-01 | 2008-09-01 | Resolution Chemicals Ltd | Fremstilling af delta-9-tetrahydrocannabinol |
-
2003
- 2003-02-03 DK DK03702721T patent/DK1474412T3/da active
- 2003-02-03 US US10/503,082 patent/US7524881B2/en not_active Expired - Lifetime
- 2003-02-03 SI SI200331290T patent/SI1474412T1/sl unknown
- 2003-02-03 JP JP2003564030A patent/JP2005526715A/ja active Pending
- 2003-02-03 CA CA002474951A patent/CA2474951A1/en not_active Abandoned
- 2003-02-03 EP EP03702721A patent/EP1474412B1/en not_active Expired - Lifetime
- 2003-02-03 EP EP07005421A patent/EP1803717B1/en not_active Expired - Lifetime
- 2003-02-03 AT AT03702721T patent/ATE396984T1/de not_active IP Right Cessation
- 2003-02-03 BR BR0307330-0A patent/BR0307330A/pt active Search and Examination
- 2003-02-03 DE DE60321318T patent/DE60321318D1/de not_active Expired - Lifetime
- 2003-02-03 CN CNA2007100073695A patent/CN100999513A/zh active Pending
- 2003-02-03 DE DE60332776T patent/DE60332776D1/de not_active Expired - Lifetime
- 2003-02-03 NZ NZ552547A patent/NZ552547A/en not_active IP Right Cessation
- 2003-02-03 CN CNA038074168A patent/CN1642934A/zh active Pending
- 2003-02-03 AU AU2003205844A patent/AU2003205844B2/en not_active Ceased
- 2003-02-03 WO PCT/GB2003/000441 patent/WO2003064407A2/en active IP Right Grant
- 2003-02-03 ES ES03702721T patent/ES2305437T3/es not_active Expired - Lifetime
- 2003-02-03 NZ NZ534430A patent/NZ534430A/en not_active IP Right Cessation
- 2003-02-03 PT PT03702721T patent/PT1474412E/pt unknown
-
2004
- 2004-07-26 ZA ZA200405938A patent/ZA200405938B/en unknown
- 2004-07-28 NO NO20043209A patent/NO20043209L/no not_active Application Discontinuation
- 2004-07-30 US US10/902,698 patent/US7592468B2/en not_active Expired - Lifetime
-
2006
- 2006-12-29 AU AU2006252300A patent/AU2006252300B2/en not_active Ceased
-
2009
- 2009-06-18 US US12/487,185 patent/US20090253783A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7524881B2 (en) | 2009-04-28 |
EP1803717A3 (en) | 2007-07-11 |
US20090253783A1 (en) | 2009-10-08 |
PT1474412E (pt) | 2008-07-04 |
ATE396984T1 (de) | 2008-06-15 |
EP1474412A2 (en) | 2004-11-10 |
BR0307330A (pt) | 2004-12-07 |
US20050171361A1 (en) | 2005-08-04 |
ZA200405938B (no) | 2006-05-31 |
WO2003064407A2 (en) | 2003-08-07 |
EP1803717A2 (en) | 2007-07-04 |
AU2006252300B2 (en) | 2009-02-12 |
DE60321318D1 (de) | 2008-07-10 |
US7592468B2 (en) | 2009-09-22 |
NZ552547A (en) | 2008-03-28 |
EP1474412B1 (en) | 2008-05-28 |
CA2474951A1 (en) | 2003-08-07 |
JP2005526715A (ja) | 2005-09-08 |
NZ534430A (en) | 2007-09-28 |
EP1803717B1 (en) | 2010-05-26 |
WO2003064407A3 (en) | 2003-10-16 |
US20050049298A1 (en) | 2005-03-03 |
ES2305437T3 (es) | 2008-11-01 |
DE60332776D1 (de) | 2010-07-08 |
SI1474412T1 (sl) | 2008-10-31 |
AU2003205844B2 (en) | 2006-10-12 |
DK1474412T3 (da) | 2008-09-01 |
AU2006252300A1 (en) | 2007-01-25 |
CN100999513A (zh) | 2007-07-18 |
CN1642934A (zh) | 2005-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20043209L (no) | Fremstilling av A9 tetrahydrocannabinol | |
NO20062092L (no) | Nye fremgangsmater for fremstilling av N-desmetylzopiklon og optisk rent (+)-N-desmetylzopiklon og optisk rent (-)-N-desmetylzopiklon | |
BRPI0318811B8 (pt) | derivados de ciclohexanol espirocíclicos | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
ECSP056016A (es) | Nuevos derivados de 2-piridinacarboxamida | |
PT1133283E (pt) | Um metodo de producao de particulas de farmaco | |
BRPI0414598A (pt) | indóis substituìdos | |
WO2001089571A3 (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
ATE252571T1 (de) | Tocotrienole und geranylgeraniol aus nebenprodukten von bixa orellana | |
DK1745010T3 (da) | Substituerede cyklohexyl-1,4-diaminderivater | |
UY26133A1 (es) | Derivado sustituido de pirazol. | |
EA200200096A1 (ru) | Новые производные витамина d с циклическими субструктурами в боковых цепях, способ и промежуточные продукты для их получения и их применение для получения лекарственных средств | |
UY26951A1 (es) | Derivados de ácido propiónico | |
MXPA04006803A (es) | Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma. | |
WO2003029391A1 (fr) | Procede de production de compositions de matiere grasse renfermant de l'acide oleanolique et/ou de l'acide maslinique | |
BR0309357A (pt) | Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas | |
IT1319195B1 (it) | Processo per la produzione dell'acido r(+)alfa-lipoico. | |
NO20052329L (no) | Fremgangsmate for rensingen av 1,4-butandiol-mononitrat | |
IL153830A0 (en) | A PROCESS FOR THE PREPARATION OF alpha' CHLOROKETONES | |
EP1258478A4 (en) | PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLIC ACIDS AND THEIR INTERMEDIATE PRODUCTS | |
BR0116918A (pt) | Preparação de warfarin sódico a partir do ácido de warfarin | |
BR0207953A (pt) | Derivados de caloporosida, processos para a sua preparação e sua aplicação | |
ES8800200A1 (es) | Un proceso para produccion de un derivado del indol. | |
DK1109782T3 (da) | Fremgangsmåde til fremstilling af N-beskyttede azetidin-2-carboxylsyrer (AzeOH'er) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |